Peter Harris award lectureHistory and prospects in calcium antagonist research
References (24)
- et al.
Calcium antagonists: Mechanisms and therapeutic uses
Trends in Pharmacological Sciences
(1984) - et al.
The role of calcium in the pathogenesis of experimental arteriosclerosis
Trends in Pharmacological Sciences (TIPS)
(1987) Biochemical aspects of prenylamine action. Preliminary communication
- et al.
Influence of prenylamine on the utilization of high energy phosphates in cardiac muscle
Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions
Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle
Ann Rev Pharmacol Toxicol
(1977)- et al.
Die elektro-mechanische Entkoppelung der glatten Gefäßmuskulatur als Grundprinzip der Coronardilatation durch 4-(2′-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäure-dimethylester (Bay a 1040, Nifedipin)
Arzneim.-Forsch. (Drug Res.)
(1972) Role of transmembrane Ca2+ supply in phasic and tonic activation of vascular smooth muscle—Vasodilator efficacy of calcium antagonists
- et al.
New pharmacological aspects of various dihydropyridine calcium antagonists with regard to smooth muscle relaxation
Control of coronary spasm by calcium antagonists
Suppression of experimental coronary spasms by major calcium antagonists
Cited by (15)
Molecular effects of new calcium antagonists: Is the principle of parcimony out of place?
2008, Annales de Cardiologie et d'AngeiologieClinical pharmacology of antihypertensive drugs
2002, Cardiology ClinicsCalpain activity alters in rat myocardial subfractions after ischemia or reperfusion
1993, BBA - Molecular Basis of DiseaseLacidipine: A dihydropyridine calcium antagonist with antioxidant activity
1992, Free Radical Biology and Medicine
Copyright © 1990 Published by Elsevier Ltd.